US delays 90 days rule restricting imported medicines from Canada and overseas

The Trump administration has postponed for 90 days a federal rule that could restrict Americans from buying prescription drugs from licensed international pharmacies, including Canadian sources. The delay suggests a policy reversal or internal reconsideration amid pressure over drug pricing and access. This matters as it affects cross-border pharmaceutical supply chains and US drug pricing dynamics.